Clinical Trials Related to Locally Advanced or Metastatic Breast Cancer

Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Status

TERMINATED

Phase

PHASE1